25 May 2013
Keywords: gsk/xenoport, submit, nda, solzira, uk, drug, major
Article | 22 September 2008
UK drug major GlaxoSmithKline and USA-based Xenoport have submitted a New Drug Application to the US Food and Drug Administration ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
22 September 2008
24 May 2013
© 2013 thepharmaletter.com